{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T03:14:15Z","timestamp":1791429255944,"version":"4.3.3"},"reference-count":46,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,3,29]],"date-time":"2021-03-29T00:00:00Z","timestamp":1616976000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006396","name":"Alexion Pharmaceuticals Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006396","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.ymgme.2021.03.011","type":"journal-article","created":{"date-parts":[[2021,3,26]],"date-time":"2021-03-26T19:43:15Z","timestamp":1616787795000},"page":"113-121","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Investigation of ALPL variant states and clinical outcomes: An analysis of adults and adolescents with hypophosphatasia treated with asfotase alfa"],"prefix":"10.1016","volume":"133","author":[{"given":"Priya S.","family":"Kishnani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillermo","family":"del Angel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanggen","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric T.","family":"Rush","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgme.2021.03.011_bb0005","series-title":"Genetics of Bone Biology and Skeletal Disease","first-page":"481","article-title":"Hypophosphatasia and how alkaline phosphatase promotes mineralization","author":"Whyte","year":"2018"},{"key":"10.1016\/j.ymgme.2021.03.011_bb0010","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1111\/j.1749-6632.2010.05387.x","article-title":"Physiological role of alkaline phosphatase explored in hypophosphatasia","volume":"1192","author":"Whyte","year":"2010","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"Suppl. 2","key":"10.1016\/j.ymgme.2021.03.011_bb0015","first-page":"380","article-title":"Hypophosphatasia","volume":"10","author":"Rockman-Greenberg","year":"2013","journal-title":"Pediatr. Endocrinol. Rev."},{"issue":"6","key":"10.1016\/j.ymgme.2021.03.011_bb0020","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1016\/j.bone.2007.01.020","article-title":"Pyridoxine-responsive seizures as the first symptom of infantile hypophosphatasia caused by two novel missense mutations (c.677T>C, p.M226T; c.1112C>T, p.T371I) of the tissue-nonspecific alkaline phosphatase gene","volume":"40","author":"Baumgartner-Sigl","year":"2007","journal-title":"Bone."},{"issue":"2","key":"10.1016\/j.ymgme.2021.03.011_bb0025","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s00198-018-4691-6","article-title":"Neurological symptoms in hypophosphatasia","volume":"30","author":"Colazo","year":"2019","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.ymgme.2021.03.011_bb0030","series-title":"The Tissue Nonspecific Alkaline Phosphatase Gene Mutations database","author":"University of Versailles-Saint Quentin","year":"2020"},{"issue":"4","key":"10.1016\/j.ymgme.2021.03.011_bb0035","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/nrendo.2016.14","article-title":"Hypophosphatasia - aetiology, nosology, pathogenesis, diagnosis and treatment","volume":"12","author":"Whyte","year":"2016","journal-title":"Nat. Rev. Endocrinol."},{"issue":"3","key":"10.1016\/j.ymgme.2021.03.011_bb0040","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s11914-016-0309-0","article-title":"Hypophosphatasia","volume":"14","author":"Linglart","year":"2016","journal-title":"Curr. Osteoporos. Rep."},{"issue":"1","key":"10.1016\/j.ymgme.2021.03.011_bb0045","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.bone.2013.01.024","article-title":"Clinical spectrum of hypophosphatasia diagnosed in adults","volume":"54","author":"Berkseth","year":"2013","journal-title":"Bone."},{"key":"10.1016\/j.ymgme.2021.03.011_bb0050","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1016\/j.metabol.2016.07.006","article-title":"Burden of disease in adult patients with hypophosphatasia: results from two patient-reported surveys","volume":"65","author":"Weber","year":"2016","journal-title":"Metabolism."},{"key":"10.1016\/j.ymgme.2021.03.011_bb0055","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1002\/jbmr.4130","article-title":"Burden of illness in adults with hypophosphatasia: data from the global Hypophosphatasia patient registry","volume":"35","author":"Seefried","year":"2020","journal-title":"J. Bone Miner. Res."},{"issue":"1","key":"10.1016\/j.ymgme.2021.03.011_bb0060","doi-asserted-by":"crossref","DOI":"10.1186\/s12891-019-2420-8","article-title":"Diagnostic delay is common among patients with hypophosphatasia: initial findings from a longitudinal, prospective, global registry","volume":"20","author":"H\u00f6gler","year":"2019","journal-title":"BMC Musculoskelet. Disord."},{"key":"10.1016\/j.ymgme.2021.03.011_bb0065","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.metabol.2017.08.013","volume":"82","author":"Mornet","year":"2018","journal-title":"Hypophosphatasia. Metabolism."},{"issue":"3","key":"10.1016\/j.ymgme.2021.03.011_bb0070","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1002\/ajmg.a.37991","article-title":"Molecular and clinical analysis of ALPL in a cohort of patients with suspicion of hypophosphatasia","volume":"173","author":"Tenorio","year":"2017","journal-title":"Am. J. Med. Genet. A"},{"issue":"11","key":"10.1016\/j.ymgme.2021.03.011_bb0075","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s11926-018-0778-5","article-title":"Hypophosphatasia: from diagnosis to treatment","volume":"20","author":"Simon","year":"2018","journal-title":"Curr. Rheumatol. Rep."},{"key":"10.1016\/j.ymgme.2021.03.011_bb0080","article-title":"Hypophosphatasia: a genetic-based nosology and new insights in genotype-phenotype correlation","author":"Mornet","year":"2020","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.ymgme.2021.03.011_bb0085","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.bone.2019.05.005","article-title":"A novel combination of biallelic ALPL mutations associated with adult hypophosphatasia: a phenotype-genotype association and computational analysis study","volume":"125","author":"Martins","year":"2019","journal-title":"Bone."},{"key":"10.1016\/j.ymgme.2021.03.011_bb0090","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/978-94-017-7197-9_2","article-title":"Molecular genetics of hypophosphatasia and phenotype-genotype correlations","volume":"76","author":"Mornet","year":"2015","journal-title":"Subcell. Biochem."},{"key":"10.1016\/j.ymgme.2021.03.011_bb0095","unstructured":"Strensiq [package insert]. Boston, MA: Alexion Pharmaceuticals, Inc.; June 2020."},{"key":"10.1016\/j.ymgme.2021.03.011_bb0100","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.bone.2018.12.011","article-title":"Five-year efficacy and safety of asfotase alfa therapy for adults and adolescents with hypophosphatasia","volume":"121","author":"Kishnani","year":"2019","journal-title":"Bone."},{"key":"10.1016\/j.ymgme.2021.03.011_bb0105","doi-asserted-by":"crossref","first-page":"115664","DOI":"10.1016\/j.bone.2020.115664","article-title":"Pharmacodynamics of asfotase alfa in adults with pediatric-onset hypophosphatasia","volume":"142","author":"Seefried","year":"2021","journal-title":"Bone."},{"issue":"1","key":"10.1016\/j.ymgme.2021.03.011_bb0110","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1164\/ajrccm.166.1.at1102","article-title":"ATS statement: guidelines for the six-minute walk test","volume":"166","year":"2002","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"2","key":"10.1016\/j.ymgme.2021.03.011_bb0115","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/00008483-200103000-00005","article-title":"Reference values for a multiple repetition 6-minute walk test in healthy adults older than 20 years","volume":"21","author":"Gibbons","year":"2001","journal-title":"J. Cardpulm. Rehabil."},{"issue":"4","key":"10.1016\/j.ymgme.2021.03.011_bb0120","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.jpeds.2006.12.052","article-title":"Six-minute walk test in children and adolescents","volume":"150","author":"Geiger","year":"2007","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ymgme.2021.03.011_bb0125","doi-asserted-by":"crossref","DOI":"10.1371\/currents.RRN1297","article-title":"Percent-predicted 6-minute walk distance in Duchenne muscular dystrophy to account for maturational influences","volume":"4","author":"Henricson","year":"2012","journal-title":"PLoS Curr."},{"issue":"4","key":"10.1016\/j.ymgme.2021.03.011_bb0130","first-page":"371","article-title":"The lower extremity functional scale (LEFS): scale development, measurement properties, and clinical application. North American orthopaedic rehabilitation research network","volume":"79","author":"Binkley","year":"1999","journal-title":"Phys. Ther."},{"issue":"2","key":"10.1016\/j.ymgme.2021.03.011_bb0135","first-page":"129","article-title":"Pain assessment: global use of the Brief Pain Inventory","volume":"23","author":"Cleeland","year":"1994","journal-title":"Ann. Acad. Med. Singap."},{"issue":"1","key":"10.1016\/j.ymgme.2021.03.011_bb0140","first-page":"52","article-title":"The Brief Pain Inventory (BPI)","volume":"62","author":"Poquet","year":"2016","journal-title":"Aust. J. Phys."},{"key":"10.1016\/j.ymgme.2021.03.011_bb0145","article-title":"Large-scale in vitro functional testing and novel variant scoring via protein modeling provide insights into alkaline phosphatase activity in hypophosphatasia","author":"Del Angel","year":"2020","journal-title":"Hum. Mutat."},{"issue":"6","key":"10.1016\/j.ymgme.2021.03.011_bb0150","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1093\/hmg\/8.6.1039","article-title":"Correlations of genotype and phenotype in hypophosphatasia","volume":"8","author":"Zurutuza","year":"1999","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymgme.2021.03.011_bb0155","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.bone.2015.02.022","article-title":"Hypophosphatasia: validation and expansion of the clinical nosology for children from 25 years experience with 173 pediatric patients","volume":"75","author":"Whyte","year":"2015","journal-title":"Bone."},{"issue":"3","key":"10.1016\/j.ymgme.2021.03.011_bb0160","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.ymgme.2015.09.010","article-title":"Molecular diagnosis of hypophosphatasia and differential diagnosis by targeted next generation sequencing","volume":"116","author":"Taillandier","year":"2015","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2021.03.011_bb0165","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.bonr.2016.08.004","article-title":"Case series: odontohypophosphatasia or missed diagnosis of childhood\/adult-onset hypophosphatasia? Call for a long-term follow-up of premature loss of primary teeth","volume":"5","author":"Mori","year":"2016","journal-title":"Bone Rep."},{"key":"10.1016\/j.ymgme.2021.03.011_bb0170","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/1471-2350-10-51","article-title":"Mild forms of hypophosphatasia mostly result from dominant negative effect of severe alleles or from compound heterozygosity for severe and moderate alleles","volume":"10","author":"Fauvert","year":"2009","journal-title":"BMC Med. Genet."},{"issue":"2","key":"10.1016\/j.ymgme.2021.03.011_bb0175","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1210\/jcem.85.2.6373","article-title":"Asp361Val mutant of alkaline phosphatase found in patients with dominantly inherited hypophosphatasia inhibits the activity of the wild-type enzyme","volume":"85","author":"Muller","year":"2000","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.ymgme.2021.03.011_bb0180","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s004390100546","article-title":"A molecular approach to dominance in hypophosphatasia","volume":"109","author":"Lia-Baldini","year":"2001","journal-title":"Hum. Genet."},{"issue":"6","key":"10.1016\/j.ymgme.2021.03.011_bb0185","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1007\/s00774-017-0888-6","article-title":"Genetic analysis of adults heterozygous for ALPL mutations","volume":"36","author":"Taillandier","year":"2018","journal-title":"J. Bone Miner. Metab."},{"key":"10.1016\/j.ymgme.2021.03.011_bb0190","doi-asserted-by":"crossref","first-page":"100661","DOI":"10.1016\/j.ymgmr.2020.100661","article-title":"Multigenerational case examples of hypophosphatasia: challenges in genetic counseling and disease management","volume":"25","author":"Huggins","year":"2020","journal-title":"Molec. Genet. Metab. Rep."},{"issue":"10","key":"10.1016\/j.ymgme.2021.03.011_bb0195","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1038\/sj.ejhg.5200857","article-title":"Evidence of a founder effect for the tissue-nonspecific alkaline phosphatase (TNSALP) gene E174K mutation in hypophosphatasia patients","volume":"10","author":"Herasse","year":"2002","journal-title":"Eur. J. Hum. Genet."},{"issue":"4","key":"10.1016\/j.ymgme.2021.03.011_bb0200","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1002\/(SICI)1098-1004(200004)15:4<309::AID-HUMU2>3.0.CO;2-C","article-title":"Hypophosphatasia: the mutations in the tissue-nonspecific alkaline phosphatase gene","volume":"15","author":"Mornet","year":"2000","journal-title":"Hum. Mutat."},{"issue":"10","key":"10.1016\/j.ymgme.2021.03.011_bb0205","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1038\/ejhg.2014.10","article-title":"Unexpected high intrafamilial phenotypic variability observed in hypophosphatasia","volume":"22","author":"Hofmann","year":"2014","journal-title":"Eur. J. Hum. Genet."},{"issue":"3","key":"10.1016\/j.ymgme.2021.03.011_bb0210","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1002\/ajmg.1541","article-title":"Perinatal hypophosphatasia: radiology, pathology and molecular biology studies in a family harboring a splicing mutation (648+1A) and a novel missense mutation (N400S) in the tissue-nonspecific alkaline phosphatase (TNSALP) gene","volume":"103","author":"Sergi","year":"2001","journal-title":"Am. J. Med. Genet."},{"issue":"20","key":"10.1016\/j.ymgme.2021.03.011_bb0215","doi-asserted-by":"crossref","first-page":"9924","DOI":"10.1073\/pnas.89.20.9924","article-title":"Different missense mutations at the tissue-nonspecific alkaline phosphatase gene locus in autosomal recessively inherited forms of mild and severe hypophosphatasia","volume":"89","author":"Henthorn","year":"1992","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"4","key":"10.1016\/j.ymgme.2021.03.011_bb0220","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s00439-008-0480-1","article-title":"A new mechanism of dominance in hypophosphatasia: the mutated protein can disturb the cell localization of the wild-type protein","volume":"123","author":"Lia-Baldini","year":"2008","journal-title":"Hum. Genet."},{"issue":"1","key":"10.1016\/j.ymgme.2021.03.011_bb0225","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/s13023-019-1062-0","article-title":"Frequency and age at occurrence of clinical manifestations of disease in patients with hypophosphatasia: a systematic literature review","volume":"14","author":"Szabo","year":"2019","journal-title":"Orphanet J. Rare Dis."},{"issue":"2","key":"10.1016\/j.ymgme.2021.03.011_bb0230","doi-asserted-by":"crossref","first-page":"230","DOI":"10.11138\/ccmbm\/2017.14.1.230","article-title":"Hypophosphatasia: clinical manifestation and burden of disease in adult patients","volume":"14","author":"Conti","year":"2017","journal-title":"Clin. Case Miner. Bone Metab."}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719221000779?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719221000779?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T23:27:41Z","timestamp":1761089261000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719221000779"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["S1096719221000779"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2021.03.011","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Investigation of ALPL variant states and clinical outcomes: An analysis of adults and adolescents with hypophosphatasia treated with asfotase alfa","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgme.2021.03.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}